HUP9900428A2 - Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény - Google Patents

Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény

Info

Publication number
HUP9900428A2
HUP9900428A2 HU9900428A HUP9900428A HUP9900428A2 HU P9900428 A2 HUP9900428 A2 HU P9900428A2 HU 9900428 A HU9900428 A HU 9900428A HU P9900428 A HUP9900428 A HU P9900428A HU P9900428 A2 HUP9900428 A2 HU P9900428A2
Authority
HU
Hungary
Prior art keywords
compounds
bismuth compounds
pharmaceutical composition
medium containing
bismuth
Prior art date
Application number
HU9900428A
Other languages
English (en)
Inventor
Torsten Almen
Arne Berg
Michael Droege
Klaes Golman
Jo Klaveness
Shi-Bao Yu
Original Assignee
Nycomed Imaging A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9501560.8A external-priority patent/GB9501560D0/en
Application filed by Nycomed Imaging A/S filed Critical Nycomed Imaging A/S
Publication of HUP9900428A2 publication Critical patent/HUP9900428A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/94—Bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A találmány tárgya bizműtvegyületek, melyek diagnősztikai leképezésre,különösen röntgensűgárnál, MRI-nél, űltrahangnál és izőtópősvizsgálatnál alkalmazhatók, a kőntrasztanyagők bizműtkőmplexeketés/vagy szerves bizműtvegyületeket tartalmaznak és a találmánykiterjed az ilyen bizműtvegyületeket tartalmazó kőntrasztanyagőkra. Abizműtvegyületek a gyógyászatban is hasznősak, különösenantimikrőbális szerként és fekélyellenes szerként. A találmány újbizműtvegyületekre is kiterjed. ŕ
HU9900428A 1995-01-26 1996-01-26 Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény HUP9900428A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501560.8A GB9501560D0 (en) 1995-01-26 1995-01-26 Contrast agents
US08/486,225 US5817289A (en) 1995-01-26 1995-06-07 Non-cluster type bismuth compounds

Publications (1)

Publication Number Publication Date
HUP9900428A2 true HUP9900428A2 (hu) 1999-06-28

Family

ID=26306382

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900428A HUP9900428A2 (hu) 1995-01-26 1996-01-26 Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény

Country Status (11)

Country Link
US (1) US6117412A (hu)
EP (1) EP0805815B1 (hu)
JP (1) JPH10512877A (hu)
CN (1) CN1177357A (hu)
AU (1) AU4493796A (hu)
CA (1) CA2211873A1 (hu)
DE (1) DE69620582T2 (hu)
FI (1) FI973117A (hu)
HU (1) HUP9900428A2 (hu)
NO (1) NO973459L (hu)
WO (1) WO1996022994A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE19635419C1 (de) * 1996-08-23 1998-08-20 Schering Ag Wismutdendrimere und ihre Verwendung als Röntgenkontrastmittel
KR100721365B1 (ko) * 2003-04-08 2007-05-23 토소가부시키가이샤 신규 비스무트 화합물, 그 제조방법 및 막의 제조방법
WO2005014567A1 (en) * 2003-08-12 2005-02-17 Biocon Limited Mycophenolic acid bismuth salt
KR101699142B1 (ko) 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 신규 항원-결합 폴리펩티드 및 이의 용도
CN1986554B (zh) * 2005-12-20 2010-08-11 上海化学试剂研究所 三(4-乙氧基苯基)铋的制备方法
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
WO2009143388A2 (en) * 2008-05-21 2009-11-26 Carnegie Mellon University Luminescent multimodal nanoparticle probe system and method of manufacture thereof
CN103518135B (zh) 2011-03-11 2016-08-17 内布拉斯加大学董事委员会 冠状动脉疾病的生物标志物
CN103771456A (zh) * 2012-10-26 2014-05-07 吴学文 一种铁氰化铋化合物及其纳米ct造影剂的制备方法
US10377775B2 (en) 2014-12-04 2019-08-13 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end
JP6460937B2 (ja) * 2014-12-04 2019-01-30 信越化学工業株式会社 末端にアミノ基を有するポリアルキレングリコール誘導体の製造方法
US9708350B2 (en) 2014-12-04 2017-07-18 Shin-Etsu Chemical Co., Ltd. Method for producing polyalkylene glycol derivative having amino group at end, polymerization initiator for use in the same, and alcohol compound as raw material for the polymerization initiator
PT3383920T (pt) 2015-11-30 2024-04-15 Univ California Entrega de carga útil específica para tumores e ativação imune utilizando um anticorpo humano que tem como alvo um antigénio altamente específico da superfície das células tumorais
US12049511B2 (en) 2016-11-10 2024-07-30 Fortis Therapeutics, Inc. Engineered CD46-specific effector cells and uses thereof in the treatment of cancer
KR102679412B1 (ko) 2018-03-16 2024-07-01 가부시끼가이샤 도꾸야마 비스무트 화합물, 경화성 조성물 및 경화체
CN115702176B (zh) 2020-07-17 2024-05-03 株式会社德山 固化性组合物及其固化体
CN116419747A (zh) 2020-08-07 2023-07-11 福蒂斯治疗公司 靶向cd46的免疫偶联物及其使用方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003685A (en) * 1961-06-29 1965-09-08 American Cyanamid Co Improvements in or relating to germicidal finishes
US3239411A (en) * 1962-06-14 1966-03-08 M & T Chemicals Inc Organo bismuth biocide
US3247050A (en) * 1962-10-11 1966-04-19 M & T Chemicals Inc Organo bismuth biocide
US3466366A (en) * 1963-05-15 1969-09-09 M & T Chemicals Inc Method of controlling bacteria with an organobismuth ethylenic carboxylate and polymer thereof
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
US3753990A (en) * 1972-01-17 1973-08-21 Procter & Gamble Phenylbismuth bis(2-pyridinethiol 1-oxide)
BE809388A (en) * 1974-01-04 1974-05-02 Bismuthyl prostanoate derivs for ulcer control - in digestive system and prepd from prostanoic acid with bismuth oxide, hydroxide or salt
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4826673A (en) * 1985-01-09 1989-05-02 Mallinckrodt, Inc. Methods and compositions for enhancing magnetic resonance imaging
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
JPS63225381A (ja) * 1986-08-29 1988-09-20 Nippon Zeon Co Ltd 肝疾患治療剤
US5482700A (en) * 1987-03-31 1996-01-09 Schering Aktiengesellschaft Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast
US5198208A (en) * 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法
CH679582A5 (hu) * 1988-07-18 1992-03-13 Glaxo Group Ltd
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
US5013560A (en) * 1989-03-17 1991-05-07 The Procter & Gamble Company Microbially-stable bismuth-containing liquid pharmaceutical suspensions
US5260304A (en) * 1989-09-07 1993-11-09 Gerhard Gergely Pharmaceutical preparation binding with gastric acid
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
WO1992017215A1 (en) * 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
ES2084174T3 (es) * 1990-07-20 1996-05-01 Tillotts Pharma Ag Productos y procesos para el tratamiento del conducto alimentario.
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
CA2052698A1 (en) * 1990-10-11 1992-04-12 Roger G. Berlin Treatment of peptic ulcer
DE69231966T2 (de) * 1991-08-05 2001-11-15 Mallinckrodt, Inc. Schwermetallcluster zur verwendung als abbildungsmittel
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
JP3668983B2 (ja) * 1993-08-23 2005-07-06 日産化学工業株式会社 トリス（置換フェニル）ビスマス誘導体
US5482669A (en) * 1994-05-23 1996-01-09 General Motors Corporation Pulsating gas-assisted injection molding method and apparatus
CZ166797A3 (en) * 1994-11-30 1997-11-12 Schering Ag Application of metal complexes as liver and gallbladder x-ray diagnostic agents
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents

Also Published As

Publication number Publication date
NO973459D0 (no) 1997-07-25
DE69620582D1 (de) 2002-05-16
NO973459L (no) 1997-09-25
DE69620582T2 (de) 2002-11-07
WO1996022994A1 (en) 1996-08-01
FI973117A0 (fi) 1997-07-25
CN1177357A (zh) 1998-03-25
EP0805815A1 (en) 1997-11-12
AU4493796A (en) 1996-08-14
CA2211873A1 (en) 1996-08-01
FI973117A (fi) 1997-09-25
JPH10512877A (ja) 1998-12-08
MX9705609A (es) 1997-10-31
EP0805815B1 (en) 2002-04-10
US6117412A (en) 2000-09-12

Similar Documents

Publication Publication Date Title
HUP9900428A2 (hu) Bizmutvegyületek, ezeket tartalmazó diagnosztikai kontrasztanyag, ennek alkalmazása és ezt tartalmazó gyógyászati készítmény
ATE113604T1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
ATE26705T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung, und pharmazeutische praeparate, die diese verbindungen enthalten.
DE58909463D1 (de) Neue kondensierte heterocyclische Verbindungen und ihre Verwendung für Heilmittel.
BR9707053B1 (pt) compostos contendo perfluoralquila e composiÇço farmacÊutica.
FR2602145B3 (fr) Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn
CL2004001126A1 (es) Complejos de polimeros en cascada y sus composiciones farmaceuticas, utiles para la preparacion de agentes de diagnostico por nmr.
IS2059B (is) Lífefnafræðilega virkjuð skuggaefni til myndgreiningar
FI93830B (fi) Typpipitoisia syklisiä ligandeja, menetelmä niiden valmistamiseksi sekä niiden käyttö metallikompleksien ja näitä komplekseja sisältävien diagnostisten koostumusten valmistamiseksi
ATE508754T1 (de) Dentales abform- oder filmmaterial und abbildungsverfahren für intraorale diagnosezwecke
ATE7699T1 (de) Cephalosporinderivate, sie enthaltende pharmazeutische praeparate und verfahren zu ihrer herstellung.
EP0137440A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0137441A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
DE68913762D1 (de) Diarylverbindungen als antiatherosklerotische Mittel.
DE69628336D1 (de) Behandlung und diagnose helicobacter pylori infektionen
SE8801719D0 (sv) Antibakteriella tandfyllnads- och cementeringsmaterial
RU93005029A (ru) Трициклические соединения, содержащие гетероатомы
IT1079776B (it) Dispositivo e procedimento per l'esame non distruttivo di materiali mediante ultrasuoni
DE60226324D1 (de) Glykopeptide, deren herstellung und verwendung in der diagnose oder behandlung von multipler sklerose
EP0379132A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
IT981155B (it) Procedimento per la preparazione di reagenti di grignard e loro impiego in sintesi organiche
ATE92052T1 (de) Leukotrien-antagonisten.
AU8144894A (en) Biphenyl iodinated derivatives and their diagnostic use
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
ES2021944A6 (es) Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno.